Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic.
Gendron N, Helley D, Thaler J, Faille D, Le Beller C, Gruest M, Hadjadj J, Philippe A, Zeco F, Courbebaisse M, Darnige L, Amara W, Calmette L, Parfait B, Auditeau C, Chocron R, Khider L, Mauge L, Espitia O, Friedlander G, Ajzenberg N, Lebeaux D, Planquette B, Sanchez O, Diehl JL; COVID-HOP Study Group; Lillo-Le Louet A, Terrier B, Smadja DM.
Gendron N, et al. Among authors: le beller c.
Res Pract Thromb Haemost. 2025 Feb 9;9(1):102701. doi: 10.1016/j.rpth.2025.102701. eCollection 2025 Jan.
Res Pract Thromb Haemost. 2025.
PMID: 40123654
Free PMC article.